No Data
No Data
CHINA SHINEWY P To Go Ex-Dividend On April 29th, 2024 With 1.17823 USD Dividend Per Share
Shenwei Pharmaceutical is happy to report that annual profit attributable to shareholders is expected to increase by about 30% to 36% year over year
Shenwei Pharmaceutical (02877) announced that the profit attributable to the company's owners for the year ended December 31, 2023 is expected to increase by about 30% to 36% compared to the same period last year (2022: about RMB 723 million). The expected increase in profit attributable to company owners this year is mainly due to an increase in the Group's overall sales revenue of about 14% compared to last year and a decrease of about 2 to 3 percent in the ratio of sales and distribution costs to turnover compared to last year.
CCB International: Maintaining Shenwei Pharmaceutical's “Outperforming Market” Rating, Target Price Reduced to HK$9.5
According to a research report released by CCB International, the target price of Shenwei Pharmaceutical (02877) was lowered by 13.6%, from HK$11 to HK$9.5, and its earnings forecast for FY2024 was RMB 1.249, reflecting the worsening sentiment of volume procurement (VBP) of traditional Chinese medicine formula granules on the Chinese pharmaceutical industry listed in Hong Kong, but it still maintained an “outperforming market” rating. The dividend rate was 7% from 2023, benefiting from strong cash flow. According to the report, the average price of traditional Chinese medicine formula granules GPO/VBP (Group Purchasing Organization/Volume Procurement) fell 50% year over year. Despite this, the third in 2023
CHINA SHINEWY P To Go Ex-Dividend On September 11th, 2023 With 0.30073 USD Dividend Per Share
Shenwei Pharmaceutical announced interim results, net profit of 491 million yuan, up 48.4% year-on-year
Shenwei Pharmaceutical (02877) announced its 2023 interim results, with a turnover of 2,399 billion yuan (RMB, same below), up 32.1% year on year, another record high in mid-term sales performance; net profit of 491 million yuan, up 48.4% year on year; basic profit of 65 points per share, and proposed an interim dividend of 11 points per share.
Shenwei Pharmaceutical will pay a second interim dividend of 0.11 yuan per share on September 29
Shenwei Pharmaceutical (02877) announced that the company will pay a second interim dividend of RMB 0.11 per share on September 29, 2023.
No Data